A new investigation has found that the U.S. Food and Drug Administration (FDA) raised concerns about Paragard IUD breakages in 2022 after inspecting the facility where the IUD is
Kratom has been touted as a mood enhancer, an energy booster, a pain reliever, and a way to combat opioid addiction. At the same time, products containing kratom have been
In August of 2022, after much back-and-forth in Congress, the country’s top lawmakers passed the Camp Lejeune Justice Act (CLJA). The legislation paved the way for the victims of
In recent years, some diabetes medications have soared in popularity for their effectiveness in controlling weight loss. These drugs contain semaglutide or tirzepatide as their primary ingredients and belong to
A Bravo reality television star’s experience with Stevens-Johnson syndrome (SJS) is shining light on the rare condition, which can be fatal in severe cases. Kyle Viljoen, a former cast
The August 10 deadline for Camp Lejeune toxic water claims to be filed under the Camp Lejeune Justice Act is approaching.
Two years ago, the Camp Lejeune Justice Act (CLJA)
A new study published in the Journal of Clinical Oncology has linked talc powder to ovarian cancer. The research, which was published last month, found that women who used talc-based
Millions of Americans who use chemical hair straightener products may have been putting their health at risk for years. In October 2023, the FDA proposed a ban on formaldehyde and
For more than 30 years, the water at Camp Lejeune in North Carolina contained toxic chemicals. Servicemembers, their family members, and civilians unknowingly drank and bathed in contaminated water for
The Federal Correctional Institution in Dublin, California (FCI-Dublin) served as the sole women-only federal prison east of the Rocky Mountains for decades, and its list of former residents includes Heidi
For millions of Americans diagnosed with diabetes, this may mean a lifetime of uncertainty, monitoring their diet and blood sugar levels. Some may require medication to treat their diabetes when
Philips Respironics will pay $1.1 billion to people who used the company’s CPAP, BiPAP, and ventilator devices and suffered injuries from foam degradation. The settlement, announced earlier this
